Similar to SARS-CoV infection, effective transmission of MERS-CoV resulted in downregulation of Th2 and high frequencies of reactive CD8+ T cells in the first phase of the disease, but not in the convalescent phase [43,44]. The gene discussed is CD8A; the disease is severe acute respiratory syndrome.